Role of Individual MARK Isoforms in Phosphorylation of Tau at Ser262 in Alzheimer's Disease

被引:60
|
作者
Gu, Gucci Jijuan [1 ]
Lund, Harald [2 ,3 ,4 ]
Wu, Di [1 ]
Blokzijl, Andries [1 ]
Classon, Christina [1 ]
von Euler, Gabriel [2 ,3 ,4 ]
Landegren, Ulf [1 ]
Sunnemark, Dan [2 ,3 ,4 ]
Kamali-Moghaddam, Masood [1 ]
机构
[1] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden
[2] CNS, IMed, Dept Neurosci, Sodertalje, Sweden
[3] AstraZeneca Res & Dev, S-15185 Sodertalje, Sweden
[4] Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med L8 04, S-17176 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Alzheimer's disease; MARK; Phosphorylation; Proximity ligation; Tau; AFFINITY-REGULATING KINASE; PROTEIN; BINDING; TANGLES; FAMILY;
D O I
10.1007/s12017-013-8232-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The microtubule-affinity regulating kinase (MARK) family consists of four highly conserved members that have been implicated in phosphorylation of tau protein, causing formation of neurofibrillary tangles in Alzheimer's disease (AD). Understanding of roles by individual MARK isoform in phosphorylating tau has been limited due to lack of antibodies selective for each MARK isoform. In this study, we first applied the proximity ligation assay on cells to select antibodies specific for each MARK isoform. In cells, a CagA peptide specifically and significantly inhibited tau phosphorylation at Ser(262) mediated by MARK4 but not other MARK isoforms. We then used these antibodies to study expression levels of MARK isoforms and interactions between tau and individual MARK isoforms in postmortem human brains. We found a strong and significant elevation of MARK4 expression and MARK4-tau interactions in AD brains, correlating with the Braak stages of the disease. These results suggest the MARK4-tau interactions are of functional importance in the progression of AD and the results also identify MARK4 as a promising target for AD therapy.
引用
收藏
页码:458 / 469
页数:12
相关论文
共 50 条
  • [1] Role of Individual MARK Isoforms in Phosphorylation of Tau at Ser262 in Alzheimer’s Disease
    Gucci Jijuan Gu
    Harald Lund
    Di Wu
    Andries Blokzijl
    Christina Classon
    Gabriel von Euler
    Ulf Landegren
    Dan Sunnemark
    Masood Kamali-Moghaddam
    NeuroMolecular Medicine, 2013, 15 : 458 - 469
  • [2] Effect of cortistatin on tau phosphorylation at Ser262 site
    Rubio, Alicia
    Perez, Mar
    de Lecea, Luis
    Avila, Jesus
    JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (11) : 2462 - 2475
  • [3] The Interplay between GSK3β and Tau Ser262 Phosphorylation during the Progression of Tau Pathology
    Song, Liqing
    Oseid, Daniel E.
    Wells, Evan A.
    Robinson, Anne Skaja
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [4] Elevated MARK2-Dependent Phosphorylation of Tau in Alzheimer's Disease
    Gu, Gucci Jijuan
    Wu, Di
    Lund, Harald
    Sunnemark, Dan
    Kvist, Alexander J.
    Milner, Roy
    Eckersley, Sonia
    Nilsson, Lars N. G.
    Agerman, Karin
    Landegren, Ulf
    Kamali-Moghaddam, Masood
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 (03) : 699 - 713
  • [5] Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262
    Saito, Taro
    Oba, Toshiya
    Shimizu, Sawako
    Asada, Akiko
    Iijima, Koichi M.
    Ando, Kanae
    HUMAN MOLECULAR GENETICS, 2019, 28 (18) : 3062 - 3071
  • [6] MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies
    Lund, Harald
    Gustafsson, Elin
    Svensson, Anne
    Nilsson, Maria
    Berg, Margareta
    Sunnemark, Dan
    von Euler, Gabriel
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [7] The Cellular Distribution and Ser262 Phosphorylation of Tau Protein Are Regulated by BDNF In Vitro
    Chen, Qian
    Zhou, Zhou
    Zhang, Lei
    Xu, Shangcheng
    Chen, Chunhai
    Yu, Zhengping
    PLOS ONE, 2014, 9 (03):
  • [8] Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated
    Ando, Kanae
    Oka, Mikiko
    Ohtake, Yosuke
    Hayashishita, Motoki
    Shimizu, Sawako
    Hisanaga, Shin-ichi
    Iijima, Koichi M.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 478 (02) : 929 - 934
  • [9] Tau Aggregation in Alzheimer's Disease What Role for Phosphorylation?
    Lippens, Guy
    Sillen, Alain
    Landrieu, Isabelle
    Amniai, Laziza
    Sibille, Nathalie
    Barbier, Pascale
    Leroy, Arnaud
    Hanoulle, Xavier
    Wieruszeski, Jean-Michel
    PRION, 2007, 1 (01) : 21 - 25
  • [10] MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies
    Harald Lund
    Elin Gustafsson
    Anne Svensson
    Maria Nilsson
    Margareta Berg
    Dan Sunnemark
    Gabriel von Euler
    Acta Neuropathologica Communications, 2